Quarterly Earnings

Progyny signals better-than-expected 2025 results on robust member engagement, sparking analyst upgrades and sending its stock soaring ahead of a key conference.

The pediatric device firm posted 15% growth to $236.1M in 2025, issuing strong 2026 guidance fueled by its specialty bracing and European expansion.

The burger chain posted positive sales and aggressive 2026 growth plans, navigating weather woes and inflation with new menu items and operational tweaks.

As Celanese prepares to report its Q4 2025 results, investors and analysts are watching for signs of recovery and strategic clarity in a volatile market.

As Triumph Financial preps its Q4 2025 results, investors watch to see if its tech investments can deliver on high growth expectations amid a complex freight market.

IDEXX prepares to release its 2025 results, with all eyes on whether its high-tech product launches can sustain momentum in a complex pet care market.

Beyond a simple time change, Fortrea's upcoming JPM presentation is a critical test for its new CEO and a key moment to define its future in the CRO market.

Gartner recognizes Jamf as a Leader in endpoint management, highlighting the growing dominance of specialized, Apple-centric solutions in the enterprise.

CVS Health is set to reveal its 2025 results. Will its integrated strategy pay off amid rising costs, PBM scrutiny, and a key Aetna turnaround?

Newly-formed materials giant Magnera reports Q1 results on Feb 5. Investors eye its path to profitability while the industry watches for key market signals.

The oil and gas firm raised its quarterly payout to $0.40/share, rewarding investors and underscoring its financial health and disciplined strategy.

With record revenue and a bold AI strategy, Opera heads to a key investor conference. Can its 'agentic' browsers redefine the web and win market share?

With blockbuster preliminary sales and rapid patient adoption, Liquidia's new inhaled therapy is challenging established players in the lung disease space.

The institutional crypto exchange reported a sharp decline in spot trading for December, but a massive surge in options volume points to a maturing market.

ChipMOS reports stunning 20.8% Q4 growth, highlighting a memory chip frenzy fueled by AI and datacenters. Is this the start of a new tech supercycle?

Sanuwave Health posts record revenue, defying industry-wide turmoil as reimbursement cuts reshape the advanced wound care market. How did they do it?

AS Tallinna Sadam reports robust 2025 results, with a major jump in liquid bulk cargo and a strong rebound in cruise tourism signaling regional recovery.

With a 12% increase in gold reserves, Aris Mining's Segovia mine proves its mettle as a world-class asset, fueling an aggressive expansion in South America.

As Copa Holdings prepares its Q4 2025 results, investors and analysts will scrutinize if the airline can sustain its stellar performance and margins.

Operational failures at a key Texas plant and a sudden drop in chlorine demand force chemical giant Olin Corp. to drastically cut its Q4 earnings forecast.